Global Roadside Drug Testing Devices Market by End User (Drug Enforcement Agencies, Highway Police), by Sample Type (Urine, Saliva, Sweat), by Substance (Alcohol, Drugs), by Modality (Standalone, Handheld) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Roadside Drug Testing Devices Market research report which is segmented by End User (Drug Enforcement Agencies, Highway Police), by Sample Type (Urine, Saliva, Sweat), by Substance (Alcohol, Drugs), by Modality (Standalone, Handheld), By Players/Companies Alcohol Countermeasure Systems Corp., Abbott Laboratories, MAVAND Solutions GmbH, Oranoxis Inc., AK GlobalTech Corporation, Cannabix Technologies Inc., Pacific Data Systems Pty Ltd., CareHealth America, UriTox LLC, Dragerwerk AG & Co. KgaA”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Roadside Drug Testing Devices Market Research Report |
By End User | Drug Enforcement Agencies, Highway Police |
By Sample Type | Urine, Saliva, Sweat |
By Substance | Alcohol, Drugs |
By Modality | Standalone, Handheld |
By Companies | Alcohol Countermeasure Systems Corp., Abbott Laboratories, MAVAND Solutions GmbH, Oranoxis Inc., AK GlobalTech Corporation, Cannabix Technologies Inc., Pacific Data Systems Pty Ltd., CareHealth America, UriTox LLC, Dragerwerk AG & Co. KgaA |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 200 |
Number of Tables & Figures | 140 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Roadside Drug Testing Devices Market Report Segments:
The market is segmented by End User (Drug Enforcement Agencies, Highway Police), by Sample Type (Urine, Saliva, Sweat), by Substance (Alcohol, Drugs), by Modality (Standalone, Handheld).
Roadside Drug Testing Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Roadside Drug Testing Devices Market
Overview of the regional outlook of the Roadside Drug Testing Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Roadside Drug Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Roadside Drug Testing Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Drug Enforcement Agencies
2. Highway Police
7. By Sample Type:1. Urine
2. Saliva
3. Sweat
8. By Substance:1. Alcohol
2. Drugs
9. By Modality:1. Standalone
2. Handheld
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Roadside Drug Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Roadside Drug Testing Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Roadside Drug Testing Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Roadside Drug Testing Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Roadside Drug Testing Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Roadside Drug Testing Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Roadside Drug Testing Devices Market Size & Forecast, 2018-2028
4.5.1 Roadside Drug Testing Devices Market Size and Y-o-Y Growth
4.5.2 Roadside Drug Testing Devices Market Absolute $ Opportunity
Chapter 5 Global Roadside Drug Testing Devices Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Roadside Drug Testing Devices Market Size Forecast by End User
5.2.1 Drug Enforcement Agencies
5.2.2 Highway Police
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Roadside Drug Testing Devices Market Analysis and Forecast by Sample Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Sample Type
6.1.2 Basis Point Share (BPS) Analysis by Sample Type
6.1.3 Absolute $ Opportunity Assessment by Sample Type
6.2 Roadside Drug Testing Devices Market Size Forecast by Sample Type
6.2.1 Urine
6.2.2 Saliva
6.2.3 Sweat
6.3 Market Attractiveness Analysis by Sample Type
Chapter 7 Global Roadside Drug Testing Devices Market Analysis and Forecast by Substance
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Substance
7.1.2 Basis Point Share (BPS) Analysis by Substance
7.1.3 Absolute $ Opportunity Assessment by Substance
7.2 Roadside Drug Testing Devices Market Size Forecast by Substance
7.2.1 Alcohol
7.2.2 Drugs
7.3 Market Attractiveness Analysis by Substance
Chapter 8 Global Roadside Drug Testing Devices Market Analysis and Forecast by Modality
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Modality
8.1.2 Basis Point Share (BPS) Analysis by Modality
8.1.3 Absolute $ Opportunity Assessment by Modality
8.2 Roadside Drug Testing Devices Market Size Forecast by Modality
8.2.1 Standalone
8.2.2 Handheld
8.3 Market Attractiveness Analysis by Modality
Chapter 9 Global Roadside Drug Testing Devices Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Roadside Drug Testing Devices Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Roadside Drug Testing Devices Analysis and Forecast
11.1 Introduction
11.2 North America Roadside Drug Testing Devices Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Roadside Drug Testing Devices Market Size Forecast by End User
11.6.1 Drug Enforcement Agencies
11.6.2 Highway Police
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 North America Roadside Drug Testing Devices Market Size Forecast by Sample Type
11.10.1 Urine
11.10.2 Saliva
11.10.3 Sweat
11.11 Basis Point Share (BPS) Analysis by Sample Type
11.12 Absolute $ Opportunity Assessment by Sample Type
11.13 Market Attractiveness Analysis by Sample Type
11.14 North America Roadside Drug Testing Devices Market Size Forecast by Substance
11.14.1 Alcohol
11.14.2 Drugs
11.15 Basis Point Share (BPS) Analysis by Substance
11.16 Absolute $ Opportunity Assessment by Substance
11.17 Market Attractiveness Analysis by Substance
11.18 North America Roadside Drug Testing Devices Market Size Forecast by Modality
11.18.1 Standalone
11.18.2 Handheld
11.19 Basis Point Share (BPS) Analysis by Modality
11.20 Absolute $ Opportunity Assessment by Modality
11.21 Market Attractiveness Analysis by Modality
Chapter 12 Europe Roadside Drug Testing Devices Analysis and Forecast
12.1 Introduction
12.2 Europe Roadside Drug Testing Devices Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Roadside Drug Testing Devices Market Size Forecast by End User
12.6.1 Drug Enforcement Agencies
12.6.2 Highway Police
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Europe Roadside Drug Testing Devices Market Size Forecast by Sample Type
12.10.1 Urine
12.10.2 Saliva
12.10.3 Sweat
12.11 Basis Point Share (BPS) Analysis by Sample Type
12.12 Absolute $ Opportunity Assessment by Sample Type
12.13 Market Attractiveness Analysis by Sample Type
12.14 Europe Roadside Drug Testing Devices Market Size Forecast by Substance
12.14.1 Alcohol
12.14.2 Drugs
12.15 Basis Point Share (BPS) Analysis by Substance
12.16 Absolute $ Opportunity Assessment by Substance
12.17 Market Attractiveness Analysis by Substance
12.18 Europe Roadside Drug Testing Devices Market Size Forecast by Modality
12.18.1 Standalone
12.18.2 Handheld
12.19 Basis Point Share (BPS) Analysis by Modality
12.20 Absolute $ Opportunity Assessment by Modality
12.21 Market Attractiveness Analysis by Modality
Chapter 13 Asia Pacific Roadside Drug Testing Devices Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Roadside Drug Testing Devices Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Roadside Drug Testing Devices Market Size Forecast by End User
13.6.1 Drug Enforcement Agencies
13.6.2 Highway Police
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Asia Pacific Roadside Drug Testing Devices Market Size Forecast by Sample Type
13.10.1 Urine
13.10.2 Saliva
13.10.3 Sweat
13.11 Basis Point Share (BPS) Analysis by Sample Type
13.12 Absolute $ Opportunity Assessment by Sample Type
13.13 Market Attractiveness Analysis by Sample Type
13.14 Asia Pacific Roadside Drug Testing Devices Market Size Forecast by Substance
13.14.1 Alcohol
13.14.2 Drugs
13.15 Basis Point Share (BPS) Analysis by Substance
13.16 Absolute $ Opportunity Assessment by Substance
13.17 Market Attractiveness Analysis by Substance
13.18 Asia Pacific Roadside Drug Testing Devices Market Size Forecast by Modality
13.18.1 Standalone
13.18.2 Handheld
13.19 Basis Point Share (BPS) Analysis by Modality
13.20 Absolute $ Opportunity Assessment by Modality
13.21 Market Attractiveness Analysis by Modality
Chapter 14 Latin America Roadside Drug Testing Devices Analysis and Forecast
14.1 Introduction
14.2 Latin America Roadside Drug Testing Devices Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Roadside Drug Testing Devices Market Size Forecast by End User
14.6.1 Drug Enforcement Agencies
14.6.2 Highway Police
14.7 Basis Point Share (BPS) Analysis by End User
14.8 Absolute $ Opportunity Assessment by End User
14.9 Market Attractiveness Analysis by End User
14.10 Latin America Roadside Drug Testing Devices Market Size Forecast by Sample Type
14.10.1 Urine
14.10.2 Saliva
14.10.3 Sweat
14.11 Basis Point Share (BPS) Analysis by Sample Type
14.12 Absolute $ Opportunity Assessment by Sample Type
14.13 Market Attractiveness Analysis by Sample Type
14.14 Latin America Roadside Drug Testing Devices Market Size Forecast by Substance
14.14.1 Alcohol
14.14.2 Drugs
14.15 Basis Point Share (BPS) Analysis by Substance
14.16 Absolute $ Opportunity Assessment by Substance
14.17 Market Attractiveness Analysis by Substance
14.18 Latin America Roadside Drug Testing Devices Market Size Forecast by Modality
14.18.1 Standalone
14.18.2 Handheld
14.19 Basis Point Share (BPS) Analysis by Modality
14.20 Absolute $ Opportunity Assessment by Modality
14.21 Market Attractiveness Analysis by Modality
Chapter 15 Middle East & Africa (MEA) Roadside Drug Testing Devices Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Roadside Drug Testing Devices Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Roadside Drug Testing Devices Market Size Forecast by End User
15.6.1 Drug Enforcement Agencies
15.6.2 Highway Police
15.7 Basis Point Share (BPS) Analysis by End User
15.8 Absolute $ Opportunity Assessment by End User
15.9 Market Attractiveness Analysis by End User
15.10 Middle East & Africa (MEA) Roadside Drug Testing Devices Market Size Forecast by Sample Type
15.10.1 Urine
15.10.2 Saliva
15.10.3 Sweat
15.11 Basis Point Share (BPS) Analysis by Sample Type
15.12 Absolute $ Opportunity Assessment by Sample Type
15.13 Market Attractiveness Analysis by Sample Type
15.14 Middle East & Africa (MEA) Roadside Drug Testing Devices Market Size Forecast by Substance
15.14.1 Alcohol
15.14.2 Drugs
15.15 Basis Point Share (BPS) Analysis by Substance
15.16 Absolute $ Opportunity Assessment by Substance
15.17 Market Attractiveness Analysis by Substance
15.18 Middle East & Africa (MEA) Roadside Drug Testing Devices Market Size Forecast by Modality
15.18.1 Standalone
15.18.2 Handheld
15.19 Basis Point Share (BPS) Analysis by Modality
15.20 Absolute $ Opportunity Assessment by Modality
15.21 Market Attractiveness Analysis by Modality
Chapter 16 Competition Landscape
16.1 Roadside Drug Testing Devices Market: Competitive Dashboard
16.2 Global Roadside Drug Testing Devices Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Alcohol Countermeasure Systems Corp.
16.3.2 Abbott Laboratories
16.3.3 MAVAND Solutions GmbH
16.3.4 Oranoxis Inc.
16.3.5 AK GlobalTech Corporation
16.3.6 Cannabix Technologies Inc.
16.3.7 Pacific Data Systems Pty Ltd.
16.3.8 CareHealth America
16.3.9 UriTox LLC
16.3.10 Dragerwerk AG & Co. KgaA